Abstract:The ability of tumour cells to propagate inside the body, generating metastasis, is the cause of 90 % of cancer-associated deaths. During metastasis, cancer cells modify their migratory strategy by interacting with the surrounding environment and modulating their mechanical properties. Therefore, studying the contribution of cell biomechanics to cancer invasion could help gain a broader knowledge of the metastatic process. This work aims to develop and validate methods, techniques and platforms to study cell mechanical properties and their roles in cancer invasion. Considering that cancer cells are a heterogeneous population, we divided MDA MB 231 breast cancer cells and MDA MB 435 melanoma cancer cells into subpopulations based on their ability to move through narrow membrane pores (3um), aiming to identify the correlation between cell mechanical properties and cancer cell invasiveness. At first, we established a method to study cell elasticity and adhesion forces using atomic force microscopy. Using this technique, we found lower values of Young’s modulus and adhesion forces in the more invasive subpopulation. Transcriptome analysis, performed by our collaborators at the Beatson Cancer Institute, revealed an overexpression of the MAPK/ERK signalling pathway in these cells, causing a lower organisation of the actin filaments in the cytoskeleton and a reduction of cell stiffness and adhesion forces. We demonstrated that inhibition of the MAPK/ERK pathway, using MEK inhibitors (Trametinib and U0126), causes an increase in stiffness and adhesion forces in these cells. We also developed a high-throughput microfluidic device to investigate the link between these findings and the dynamics of cancer cell invasion in confined environments under the effect of a chemotactic gradient. Considering the influence of the tumour microenvironment in regulating the cell migratory strategy by modulating cell mechanics, we used organotypic tissue slices to develop a new platform to study cancer cell metastasis in an in vivo like model. As the first step, we developed a reliable protocol for the culture of precision cut liver slices (PCLS) to maintain their viability and morphological parameters in vitro for up to 3 days. We then established a new method to study cancer cell invasion in organotypic tissue slices. Using the MDA MB 231 cells as the model system to validate the platform, we observed that more invasive subpopulation of cells showed higher invasiveness than the original population in liver tissue, which is in agreement with previous results using the other methods or platforms (i.e. Boyden chambers, wound healing assay, collagen matrix, and in vivo model). Similar results were found in the following experiment investigating MDA MB 231 migration in organotypic brain slices. To explore the potential of this in vivo like platform for preclinical oncological drug testing, throughput had to be considered. To this end, we combined this platform with a microfluidic device previously developed for high-throughput drug testing on tissue slices and further improved the culturing technique, which resulted in increased viability and higher maintenance of morphological features for up to 7 days. The combination of this new platform with the microfluidic device could, in future, allow the simultaneous study of the effects of several drugs on cell metastasis in an in vivo like environment replicating the metastatic site.

Organotypic Platform for Studying Cancer Cell Metastasis.

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

The contribution of cell mechanical properties to cancer metastasis

Development of a Microphysiological System to Model Human Cancer Metastasis From the Colon to the Liver

A Novel Microfluidic Model Can Mimic Organ-Specific Metastasis of Circulating Tumor Cells

Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model

Development of an in vitro microfluidic model to study the role of microenvironmental cells in oral cancer metastasis

Three-Dimensional In Vitro Hydro- and Cryogel-Based Cell-Culture Models for the Study of Breast-Cancer Metastasis to Bone

Design and Construction of a Multi-Organ Microfluidic Chip Mimicking the in vivo Microenvironment of Lung Cancer Metastasis

Mimicking Tumor Metastasis Using a Transwell-Integrated Organoids-On-a-Chip Platform

Dynamic cell culture modulates colon cancer cell migration in a novel 3D cell culture system

Two channel compartmentalized microfluidic chip for real time monitoring of the metastatic cascade

An Oxygen-Concentration-Controllable Multiorgan Microfluidic Platform for Studying Hypoxia-Induced Lung Cancer-Liver Metastasis and Screening Drugs

Understanding organotropism in cancer metastasis using microphysiological systems

Characterization of three-dimensional cancer cell migration in mixed collagen-Matrigel scaffolds using microfluidics and image analysis

Abstract 3513: Developing a 3D biomimetic liver metastatic niche model for pancreatic cancer

State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?

Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy

Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis

Utilizing a High-Throughput Microfluidic Platform to Study Hypoxia-Driven Mesenchymal-Mode Cell Migration

Image-Assisted Microvessel-on-a-Chip Platform for Studying Cancer Cell Transendothelial Migration Dynamics